CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody.
about
Structure of the human lung cytochrome P450 2A13Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokersStructural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpineAflatoxin B1 metabolismSmoking-Related Gene Expression in Laser Capture-Microdissected Human Lung.Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity.Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition.Mechanisms of differential expression of the CYP2A13 7520C and 7520G alleles in human lung: allelic expression analysis for CYP2A13 heterogeneous nuclear RNA, and evidence for the involvement of multiple cis-regulatory single nucleotide polymorphismUpdate information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Potent mutagenicity of 3-methylindole requires pulmonary cytochrome P450-mediated bioactivation: a comparison to the prototype cigarette smoke mutagens B(a)P and NNK.Association between aflatoxin B1 occupational airway exposure and risk of hepatocellular carcinoma: a case-control study.Suppression of pulmonary CYP2A13 expression by carcinogen-induced lung tumorigenesis in a CYP2A13-humanized mouse model.Role of CYP2A5 in the bioactivation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice.Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse modelSelective expression of CYP2A13 in human pancreatic α-islet cells.Expression of cytochrome P450 2A13 in human non-small cell lung cancer and its clinical significance.Progress and challenges in selected areas of tobacco carcinogenesisMetabolic activation of polycyclic aromatic hydrocarbons and aryl and heterocyclic amines by human cytochromes P450 2A13 and 2A6.Effect of CYP2A13 active site mutation N297A on metabolism of coumarin and tobacco-specific nitrosamines.Transcriptional suppression of CYP2A13 expression by lipopolysaccharide in cultured human lung cells and the lungs of a CYP2A13-humanized mouse model.Toxicity studies on depleted uranium in primary rat cortical neurons and in Caenorhabditis elegans: what have we learned?Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-talk in lung carcinogenesis.Extrahepatic metabolism at the body's internal-external interfaces.Oxidation of Acenaphthene and Acenaphthylene by Human Cytochrome P450 Enzymes.Cigarette Filter Ventilation and its Relationship to Increasing Rates of Lung Adenocarcinoma.Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes.Structure-Function Studies of Naphthalene, Phenanthrene, Biphenyl, and Their Derivatives in Interaction with and Oxidation by Cytochromes P450 2A13 and 2A6.Nicotine Component of Cigarette Smoke Extract (CSE) Decreases the Cytotoxicity of CSE in BEAS-2B Cells Stably Expressing Human Cytochrome P450 2A13.[Interference of homologous sequences on the SNP study of CYP2A13 gene].Extrahepatic Drug-Metabolizing Enzymes and Their Significance
P2860
Q24302407-FD9A8CB9-D3EB-4CC2-899F-9F2EF2B48D5CQ24648582-5BE2A78A-C188-4CA2-BF01-CB445B5814FEQ27675365-B927BA51-339B-4D4E-9421-2063A719904DQ30230999-E6ED1240-833F-46EA-A6BC-BFF6C6B02EE8Q30968505-C9C01DE0-C8B0-4E8A-8791-FDA858BA28E6Q33596274-940087C1-D426-4421-AC98-86F042AEF33BQ33632288-C41DBF01-7ADD-42BB-B478-5CE411806294Q33872242-EEC2328D-EC68-4B6F-B186-246BD880FC8EQ34204238-BDDE3DDA-16EE-43C7-9C41-7B2CBDD34D1BQ34311334-3BA99359-BC7A-4ACD-8BD6-69C0398BDF86Q34422555-81DBEE8C-A8B0-4D62-BB6E-B19A8087ACB1Q35531753-FD58C663-8212-4F5C-8BE2-010990BC6061Q35847688-66D8B7CB-A165-4B0F-B59A-BE8A6654F43FQ35996452-E55A44A2-5F0F-4DF8-BB56-51713BF8C5DBQ36296210-6144A5B2-937E-42BF-8A30-28F6E7432AC3Q36878107-7A2DEF77-1B6B-4E7B-8B4D-4E5392E8284FQ36916827-EEFFD357-AE78-4819-8C02-A1CBA97DC2E0Q37018108-1E368BCA-BCFA-42F2-9681-06864D595C08Q37187993-06A5E4F9-3EA7-4DD0-BE15-BD2F085AB5F1Q37253522-7AABED70-4F7F-43C8-83AD-78F42834B5AAQ37698423-568CA692-E6BA-48D3-89A2-F03D6AF6C327Q37811619-9527EC6A-8997-4705-82BB-B5FD03B1626CQ38199198-A0B53177-725F-43CC-910F-8BA8CAB4E162Q38510496-C5C6BB25-87F5-4E1E-AC39-172063A6C788Q38774196-CBAAAAF0-8C2E-4A66-B620-A73B10D4213DQ41785690-69038462-2716-4478-8817-6E193009C9C2Q42132207-168D8E9F-F24A-4AE6-AD64-79B643507616Q42238049-9765F952-7F54-4C26-9AAA-8A6CB98FDCC9Q45722657-47DE85C6-51F8-460B-8F50-BDB88B329736Q54417586-491B89F2-2AC7-41A7-9CD9-4680B361B48AQ57258718-2AB59224-4E7C-4D53-A517-1F659C446E7F
P2860
CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
CYP2A13 in human respiratory t ...... new peptide-specific antibody.
@en
CYP2A13 in human respiratory t ...... new peptide-specific antibody.
@nl
type
label
CYP2A13 in human respiratory t ...... new peptide-specific antibody.
@en
CYP2A13 in human respiratory t ...... new peptide-specific antibody.
@nl
prefLabel
CYP2A13 in human respiratory t ...... new peptide-specific antibody.
@en
CYP2A13 in human respiratory t ...... new peptide-specific antibody.
@nl
P2093
P356
P1476
CYP2A13 in human respiratory t ...... new peptide-specific antibody.
@en
P2093
Chung S Yang
Guang-Yu Yang
Jun-Yan Hong
Kenneth R Reuhl
Li-Dong Wang
Liang-Ru Zhu
Paul E Thomas
Shou-Lin Wang
Xiao-Yang He
P304
P356
10.1124/DMD.106.011049
P577
2006-06-30T00:00:00Z